perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These GLP-1 medications safe to continue
Description
BMC medicine
Acta Crystallogr
Unlike some weight loss interventions where results vary wildly between individuals, Retatrutide showed remarkably predictable outcomes
At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
